Neurapsyc, LLC
Neurapsyc, LLC develops a proprietary wearable gait rehabilitation platform that uses asymmetric cueing to improve walking patterns in stroke and Parkinson's patients, paired with VR-enabled engagement to boost adherence. The company also researches neuroplasticity-boosting molecules, creating a dual digital and molecular therapeutic approach to brain health. Its translational research is supported by SBIR/STTR-funded programs that bridge neuroscience discoveries with clinical applications.
- Healthcare Technology
- Digital Health
- Medical Devices
- Biotechnology
- Drug Discovery & Therapeutics
- Hardware
- Augmented & Virtual Reality
- Software Only
- Artificial Intelligence
- Wellness & Fitness Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Stroke and Parkinson's patients often face limited, repetitive rehabilitation options that fail to fully leverage the brain's neuroplastic capacity, slowing recovery and reducing long-term functional gains. Existing gait training methods lack the precision and engagement needed to drive meaningful, lasting improvements in mobility and quality of life.
Solution
Neurapsyc provides a proprietary wearable gait rehabilitation platform that delivers asymmetric cueing to improve walking patterns in stroke and Parkinson's patients, with integrated VR for enhanced engagement and adherence. The company pairs this digital therapeutic approach with research into neuroplasticity-boosting molecules, creating a dual innovation strategy that targets both behavioral and biological pathways for recovery. By combining digital therapeutics and molecular innovation, Neurapsyc aims to create synergistic, personalized brain health solutions. Clinical development is supported through SBIR/STTR-funded translational research programs, connecting early-stage neuroscience discoveries with practical patient care and accelerating therapeutic validation.
Target Audience
Primary customers are stroke and Parkinson's patients in need of advanced gait rehabilitation, as well as rehabilitation clinics and clinical partners seeking science-driven, engaging therapeutic solutions.
Features
- Proprietary wearable platform using asymmetric cueing to target gait impairments specific to stroke and Parkinson's patients
- VR-enabled patient engagement to increase motivation, adherence, and immersion during rehabilitation sessions
- Research and innovation in both digital and molecular approaches to enhance brain adaptability and recovery
- SBIR/STTR-funded translational research bridging neuroscience discoveries with clinical applications
- Collaborative clinical development model partnering with academic inventors and clinical collaborators
- Over 10 years of translational expertise in neuroscience, biotech R&D, and clinical partnerships